Atlas Trials

Study of Evobrutinib in Participants With RMS

Clinical trial NCT04032171 · TERMINATED

Trial details

NCT number
NCT04032171
Sponsor
EMD Serono Research & Development Institute, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsing-remitting Multiple Sclerosis
Start date
2019-09-10
Primary completion
2020-05-20
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.